Behavioural Intervention
Mindfulness-Based Intervention for Tics
This trial is comparing two different treatments for people with Tourette's syndrome or Persistent Tic Disorders. The goal is to see which treatment is more effective in managing tics and improving the overall well-being of
Behavioural Intervention
SMA Neurofeedback for Tourette Syndrome
This trial involves using real-time brain scans to help adolescents with Tourette Syndrome or chronic tic disorder learn to control their brain activity. Participants see a graph of their brain activity and try to change it, which may help reduce their tics.
Behavioural Intervention
Temperature-Regulating Therapy for Insomnia in Tourette Syndrome
This trial tests a forehead temperature-regulating device to help adults with Tourette's disorder sleep better. The device adjusts forehead temperature to improve brain function and sleep quality.
Popular Filters
Trials for TS Patients
Behavioural Intervention
Behavioral Therapy for Tic Disorders
This trial is studying Tourette Syndrome and Persistent Motor/Vocal Tic Disorder in young people. These conditions can cause problems with functioning, emotions, and behavior. The main symptom is chronic tics. The
Selective Serotonin Reuptake Inhibitor
Sertraline for Anxiety in Neurodevelopmental Disorders
This trial seeks to determine if sertraline could help reduce anxiety in kids/youth with neurodevelopmental disorders. More research is needed to confirm its effectiveness.
Device
Transcranial Magnetic Stimulation for Tourette Syndrome
This trial will study if using a magnetic stimulation followed by therapy can reduce tics in adults with Tourette's Syndrome. It will compare changes in tic frequency/severity + neurophysiological changes.
Non-invasive Brain Stimulation
Theta Burst Stimulation for Tourette Syndrome
This trial uses a non-invasive magnetic pulse therapy to help Tourette Syndrome patients by improving their brain's ability to control movements and reduce tics. This therapy has shown promising results in reducing tic severity in Tourette Syndrome.
Trials With No Placebo
Behavioural Intervention
Behavioral Therapy for Tic Disorders
This trial is studying Tourette Syndrome and Persistent Motor/Vocal Tic Disorder in young people. These conditions can cause problems with functioning, emotions, and behavior. The main symptom is chronic tics. The
Deep Brain Stimulation
Deep Brain Stimulation for Tourette Syndrome
This trial involves using a small implantable device to help control severe tics in patients with Tourette syndrome. The device works by monitoring brain activity and sending electrical signals to specific brain areas to stop the tics. This method has been increasingly used for symptom management in severe cases of Tourette syndrome.
Cannabinoid
Medical Cannabis for Chronic Pain
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Frequently Asked Questions
Introduction to tourette syndrome
What are the top hospitals conducting tourette syndrome research?
Advancements in the understanding and treatment of Tourette syndrome are being made by top hospitals across the United States. In Nashville, Access Clinical Trials, Inc. is actively involved in two clinical trials focused on this complex neurological condition. Since their first recorded trial in 2019, they have contributed to a total of four studies related to Tourette syndrome. Further west in Salt Lake City, the University of Utah has also dedicated their efforts to understanding and managing this disorder. With two ongoing trials and four completed ones since 2010, they continue to make significant strides.
The Yale Child Study Center in New Haven is another prominent institution contributing to advancements in treating Tourette syndrome. Alongside two current clinical trials, they have conducted six previous studies since joining the field back in 2010. Meanwhile, at Johns Hopkins University School of Medicine located in Baltimore, researchers are conducting two active clinical trials for Tourette syndrome as part of their commitment towards improving patient outcomes. They too have been involved with four prior investigations since recording their first trial only recently alongside Access Clinical Trials Inc., namely last year (in 2019).
Lastly but certainly not leastly is Cincinnati Children's Hospital Medical Center situated within Cincinnati where there are currently running tests regarding this matter just like fellow counterparts mentioned above number up until two while collectively they've successfully earlier accomplished three separate experiments; all started upon commencement from around more than ten years ago specifically during early months spanning throughout year twenty-ten.
These esteemed institutions exemplify a shared goal: bettering the lives of individuals affected by Tourette syndrome through rigorous research and innovative treatments. By actively engaging patients and investing resources into clinical trials targeted at understanding this often-misunderstood condition, these hospitals play an integral role in shaping future approaches leading towards enhanced care for those living with Tourettes worldwide
Which are the best cities for tourette syndrome clinical trials?
When it comes to tourette syndrome clinical trials, several cities are at the forefront of research and development. New Haven, Connecticut leads with 5 active trials exploring treatments like TSupport (a Traditional Chinese Medicine), Neurofeedback from the SMA, and T92. Nashville, Tennessee follows closely behind with 3 ongoing studies focused on interventions such as ecopipam and Ecopipam HCl. Gainesville, Florida also offers 3 active trials investigating options like Medtronic Percept Neurostimulator and medical cannabis. Lastly, Baltimore, Maryland contributes to advancements in care through studies on Habit Reversal Training and Medtronic Activa Deep Brain Stimulation System. Together with Boston's focus on Cognitive Behavioral Therapy (CBT) among other avenues of research, these cities provide individuals with tourette syndrome access to cutting-edge clinical trials that offer hope for improved management of their condition.
Which are the top treatments for tourette syndrome being explored in clinical trials?
In the realm of clinical trials for Tourette syndrome, two treatments are making waves. The Medtronic Percept Neurostimulator, a cutting-edge device, is currently being explored in one active trial dedicated to this condition. This innovative technology entered the scene in 2022 and shows great promise. Another contender is TSupport, an intriguing Traditional Chinese Medicine solution also undergoing testing in a single active trial specific to Tourette syndrome. With both treatments having recently emerged on the scene, researchers are eagerly awaiting further results that could potentially transform the lives of individuals affected by this neurological disorder.
What are the most recent clinical trials for tourette syndrome?
Recent clinical trials have brought hope to those affected by Tourette syndrome, with promising advancements in treatment. One notable trial involves the use of ecopipam at a dosage of 1.8 mg/kg/day, showing potential benefits for individuals with Tourette syndrome. Another study examines the effectiveness of SCI-110 as a possible therapeutic option during Phase 2 testing. While an earlier trial explored the use of medical cannabis for Tourette syndrome, further research is necessary to establish its efficacy conclusively. These ongoing investigations hold promise for improving the lives and managing symptoms in individuals living with this neurological condition.
What tourette syndrome clinical trials were recently completed?
In October 2019, Emalex Biosciences Inc. successfully completed a clinical trial investigating the efficacy of Ecopipam for the treatment of Tourette syndrome. This trial represents an important step in exploring potential therapies to alleviate symptoms associated with this neurological disorder. The completion of this study showcases ongoing efforts to improve outcomes and quality of life for individuals affected by Tourette syndrome.